Agenda
| 6:30 – 7:30 am | Registration Check-In & Breakfast |
|---|---|
| 7:30 – 7:45 am | Welcome & Chairman’s Opening Remarks |
| Followed By “2014 Year In Review” | |
| 7:45 – 9:37 am | BioPharma Company Showcase |
| Co-Moderated By: Robert Dempsey, Vice President & Business Unit Head – Shire Ophthalmics Calvin W. Roberts, MD, Executive Vice President & CMO – Bausch + Lomb 7:45-7:53 – Allysta Pharmaceuticals – Henry Hsu, MD, Founder & CEO |
|
| 9:37 – 10:07 am | Networking Break |
Sponsored By: |
|
| 10:07 – 11:51 am | Device, Delivery, & Diagnostic Company Showcase |
| Co-Moderated By: Laurent Attias, Head, Global Commercial Strategy – Alcon Jane Rady, Divisional Vice President, Business Development – Abbott Medical Optics 10:07-10:15 – TearScience – Tim Willis, CEO & Co-Founder |
|
| 11:51 am – 12:21 pm | Digital Ophthalmology Showcase |
| Moderated By: Gilbert H. Kliman, MD, Managing Director – InterWest Partners 11:51-11:56 – CheckedUp – Richard M. Awdeh, MD, Founder & CEO |
|
| 12:21 – 12:41 pm | Digital Ophthalmology |
| The Alcon/Google Partnership & Beyond Panelists: Laurent Attias, Head, Global Commercial Strategy – Alcon Franck Leveiller, PhD, VP, Head of Research & Development Vision Care – Alcon Brian P. Otis, PhD, Founder, Smart Contact Lens Project – Google X Moderated By: |
|
| 12:41 pm | Lunch Commences |
| 1:10 – 1:35 pm | Plenary Keynote: Accelerating Innovation In Ophthalmology |
| Jeff George, President & Global Head – Alcon | |
| 1:35 – 2:00 pm | OIS Innovator Award Presentation |
| 2:00 pm | Luncheon Concludes |
| 2:00 – 2:07 pm | Ophthalmic Innovation 2014 |
| A View From The AAO David W. Parke, MD, CEO – American Academy of Ophthalmology |
|
| 2:07 – 2:15 pm | Ophthalmic Innovation 2014 |
| A View From The NEI Matthew J. McMahon, PhD, Director, Office of Translational Research, National Eye Institute – National Institutes of Health |
|
| 2:15 – 2:20 pm | Houston, We Have A Problem |
| Visual Disorders In Space And How Ophthalmology Can help Dorit B. Donoviel, PhD, Deputy Chief Scientist & Industry Forum Lead – National Space Biomedical Research Institute |
|
| 2:20 – 2:50 pm | FDA Q&A |
| Panelists: Wiley A. Chambers, MD, Supervisory Medical Officer, Division of Transplant & Ophthalmology Products – FDA Malvina B. Eydelman, MD, Director, Division of Ophthalmic Device Evaluation – FDA Moderated By: |
|
| 2:50 – 3:20 pm | Second Acts – Reinventing Your Company |
| Panelists: Vicente Anido Jr., PhD, CEO – Aerie Pharmaceuticals Mark Forchette, Former CEO – OptiMedica Thomas G. Frinzi, President & CEO – WaveTec Vision Systems Stuart Abelson, President & CEO – Ora Ron Kurtz, MD, Founder – Intralase Moderated By: |
|
| 3:20 – 3:50 pm | Afternoon Refreshment & Networking Break |
| Sponsored By: |
|
| 3:50 – 4:00 pm | Private Funding Trends Presentation |
| Jonathan Norris, Managing Director – SVB | |
| 4:00 – 4:10 pm | The Ophthalmology Market |
| A View Of The Public Sector & Exit Trends Jeffrey Hoffman, Managing Director & Head of West Coast Healthcare Investment Banking – J.P. Morgan |
|
| 4:10 – 4:40 pm | IPOs In Ophthalmology – The Class Of 2014 & Beyond |
| Panelists: Susan Washer, President & CEO – AGTC Amarpreet Sawhney, PhD, President & CEO – Ocular Therapeutix Vicente Anido Jr., PhD, CEO – Aerie Pharmaceuticals Brian Johnson, Partner – WilmerHale Thomas W. Chalberg, PhD, Founder & CEO – Avalanche Biotechnologies Michael Gaito, Managing Director – Head of West Coast Life Sciences – J.P. Morgan Moderated By: |
|
| 4:40 – 5:10 pm | Industry Consolidation: The Good, The Bad And The Unknown |
| Panelists: Jeff George, President & Global Head – Alcon David E.I. Pyott, CEO – Allergan Murthy V. Simhambhatla, PhD, President – Abbott Medical Optics Ashley McEvoy, Company Group Chairman – Johnson & Johnson Vision Care William J. Link, PhD, Managing Director – Versant Ventures Moderated By: |
|
| 5:10 pm | Wrap-Up & Closing Comments |
| 5:10 – 6:30 pm | Cocktail Reception |